| Daniel Robert More, MD | |
|
1551 Bishop St Ste 220, San Luis Obispo, CA 93401-4661 | |
| (805) 543-2744 | |
| (805) 543-0539 |
| Full Name | Daniel Robert More |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 26 Years |
| Location | 1551 Bishop St Ste 220, San Luis Obispo, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306844279 | NPI | - | NPPES |
| GR0071130 | Medicaid | CA | |
| CB404055 | Other | CA | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | A72421 (California) | Secondary |
| 207K00000X | Allergy & Immunology | A72421 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marian Regional Medical Center | Santa maria, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Partners Of California, Inc | 0143498097 | 10 |
News Archive
New research findings show how it may be possible to render cancer tumours harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. The study was carried out at Lund University in Sweden.
The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a $16.8 million, seven-year grant to launch a bicoastal research partnership between Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium and Children's Hospital of Philadelphia.
Scientists have learned that a family of genes long known to be integral to the immune system also plays a role in vision, perhaps preventing certain blinding diseases.
Advances in technology have almost lifted the curtain on the long-awaited era of the "$1,000 genome" - a time when all the genes that make up a person can be deciphered for about that amount - compared to nearly $1 million a few years ago.
Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
› Verified 1 days ago
| Entity Name | Central Coast Allergy And Asthma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619037975 PECOS PAC ID: 8527000397 Enrollment ID: O20050523001153 |
News Archive
New research findings show how it may be possible to render cancer tumours harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. The study was carried out at Lund University in Sweden.
The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a $16.8 million, seven-year grant to launch a bicoastal research partnership between Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium and Children's Hospital of Philadelphia.
Scientists have learned that a family of genes long known to be integral to the immune system also plays a role in vision, perhaps preventing certain blinding diseases.
Advances in technology have almost lifted the curtain on the long-awaited era of the "$1,000 genome" - a time when all the genes that make up a person can be deciphered for about that amount - compared to nearly $1 million a few years ago.
Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
› Verified 1 days ago
| Entity Name | Allergy Partners Of California, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992002182 PECOS PAC ID: 0143498097 Enrollment ID: O20110719000704 |
News Archive
New research findings show how it may be possible to render cancer tumours harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. The study was carried out at Lund University in Sweden.
The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a $16.8 million, seven-year grant to launch a bicoastal research partnership between Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium and Children's Hospital of Philadelphia.
Scientists have learned that a family of genes long known to be integral to the immune system also plays a role in vision, perhaps preventing certain blinding diseases.
Advances in technology have almost lifted the curtain on the long-awaited era of the "$1,000 genome" - a time when all the genes that make up a person can be deciphered for about that amount - compared to nearly $1 million a few years ago.
Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Robert More, MD Po Box 603725, Charlotte, NC 28260-3725 Ph: (828) 575-2625 | Daniel Robert More, MD 1551 Bishop St Ste 220, San Luis Obispo, CA 93401-4661 Ph: (805) 543-2744 |
News Archive
New research findings show how it may be possible to render cancer tumours harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. The study was carried out at Lund University in Sweden.
The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a $16.8 million, seven-year grant to launch a bicoastal research partnership between Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium and Children's Hospital of Philadelphia.
Scientists have learned that a family of genes long known to be integral to the immune system also plays a role in vision, perhaps preventing certain blinding diseases.
Advances in technology have almost lifted the curtain on the long-awaited era of the "$1,000 genome" - a time when all the genes that make up a person can be deciphered for about that amount - compared to nearly $1 million a few years ago.
Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
› Verified 1 days ago
Dr. Courtney Ramos, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1551 Bishop Street, Bldg B, Suite 220, San Luis Obispo, CA 93401 Phone: 805-543-2744 Fax: 805-543-0539 | |
Kelli Marie Rose, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1551 Bishop St, Suite 520, San Luis Obispo, CA 93401 Phone: 805-543-2744 Fax: 805-543-0539 | |
Dr. Arthur Corwin Mclean, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1551 Bishop St Ste 520, San Luis Obispo, CA 93401 Phone: 805-543-2744 Fax: 805-543-0539 | |
Robert J Holzhauer, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1551 Bishop St, Suite 520, San Luis Obispo, CA 93401 Phone: 805-543-2744 Fax: 805-543-0539 |